Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/21/26
GSK hepatitis B drug approval supports £2.2bn sales forecast, Jefferies saysProactive Investors • 10/21/26
Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)Business Wire • 10/20/26
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatmentReuters • 10/20/26
Jefferies backs GSK with 2,500p target after positive lung cancer drug resultsProactive Investors • 10/19/26
GSK: Maintaining Strong Buy For LAI HIV Sales Growth And Further Oncology ExpansionSeeking Alpha • 10/14/26
GSK third quarter likely to be in line as RBC sees vaccine headwinds offset by HIV strengthProactive Investors • 10/13/26
Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobsReuters • 10/09/26
Chai Discovery Announces Collaboration with GSK Following Successful Wet-Lab EvaluationBusiness Wire • 10/09/26
Viola Davis partners with GSK to educate adults 50 and older about their shingles riskPRNewsWire • 10/08/26
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend YieldsBenzinga • 10/08/26
GSK retains ‘buy' rating at Jefferies as B7H3 cancer programme seen as underappreciatedProactive Investors • 09/29/26
GSK plc (GSK) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum TranscriptSeeking Alpha • 09/23/26
GSK plc (GSK) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 09/23/26
European drugmakers call for faster trials, more spending to compete with US, ChinaReuters • 09/22/26